A major clinical trial shows home-based UV-B phototherapy is as effective as office treatments for psoriasis, offering ...

For decades, people with psoriasis have been treated in clinics with narrowband ultraviolet B phototherapy, or light therapy, ...

Could home-based phototherapy for plaque or guttate psoriasis be just as effective as office-based treatment? Find out ...

For decades, people with psoriasis have been treated in clinics with narrowband ultraviolet B phototherapy, or light therapy, to reduce sores, scales, and inflammation. Now, new research from the ...

And beyond the physical symptoms, plaque psoriasis also frequently has negative effects on mental health and alters the ...

Report Ocean has published a new report on the Phototherapy Equipment Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...

World Psoriasis Day 2024 emphasizes the role of family in supporting individuals with psoriatic disease, raising awareness of ...

Sep. 26, 2024 — Scientists believe the hormone hepcidin, when produced in the skin, may be the root cause of psoriasis -- a chronic and sometimes debilitating skin disease that affects 2-3% of ...

Phase 3b trial evaluating Tremfya (guselkumab) in low body surface area plaque psoriasis found the treatment improved clearance.

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

When it comes to skincare, two distinct fields often come to mind: traditional dermatology and aesthetic medicine. While both ...

(RTTNews) - Johnson & Johnson (JNJ) Friday announced positive results from Phase 3b SPECTREM study of Tremfya to treat adults with low body surface area (BSA) moderate plaque psoriasis (PsO) in ...